These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 16303871

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasone.
    Jin M, Shimada T, Yokogawa K, Nomura M, Kato Y, Tsuji A, Miyamoto K.
    Int J Pharm; 2006 Feb 17; 309(1-2):81-6. PubMed ID: 16384676
    [Abstract] [Full Text] [Related]

  • 3. Site-dependent contributions of P-glycoprotein and CYP3A to cyclosporin A absorption, and effect of dexamethasone in small intestine of mice.
    Jin M, Shimada T, Yokogawa K, Nomura M, Ishizaki J, Piao Y, Kato Y, Tsuji A, Miyamoto K.
    Biochem Pharmacol; 2006 Oct 16; 72(8):1042-50. PubMed ID: 16939683
    [Abstract] [Full Text] [Related]

  • 4. Influence of cytarabine and cyclophosphamide on the disposition kinetics of cyclosporin A after bone marrow transplantation.
    Shimada T, Aoki Y, Yokogawa K, Nomura M, Ishizaki J, Nishigami J, Miyamoto K.
    Transpl Int; 2003 Nov 16; 16(11):788-93. PubMed ID: 12844214
    [Abstract] [Full Text] [Related]

  • 5. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.
    Durmus S, Xu N, Sparidans RW, Wagenaar E, Beijnen JH, Schinkel AH.
    Pharmacol Res; 2013 Oct 16; 76():9-16. PubMed ID: 23827160
    [Abstract] [Full Text] [Related]

  • 6. Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin.
    Goralski KB, Hartmann G, Piquette-Miller M, Renton KW.
    Br J Pharmacol; 2003 May 16; 139(1):35-48. PubMed ID: 12746221
    [Abstract] [Full Text] [Related]

  • 7. Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug.
    Jonker JW, Wagenaar E, van Deemter L, Gottschlich R, Bender HM, Dasenbrock J, Schinkel AH.
    Br J Pharmacol; 1999 May 16; 127(1):43-50. PubMed ID: 10369454
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ontogeny of renal P-glycoprotein expression in mice: correlation with digoxin renal clearance.
    Pinto N, Halachmi N, Verjee Z, Woodland C, Klein J, Koren G.
    Pediatr Res; 2005 Dec 16; 58(6):1284-9. PubMed ID: 16306209
    [Abstract] [Full Text] [Related]

  • 10. Minor compensatory changes in SAGE Mdr1a (P-gp), Bcrp, and Mrp2 knockout rats do not detract from their utility in the study of transporter-mediated pharmacokinetics.
    Zamek-Gliszczynski MJ, Goldstein KM, Paulman A, Baker TK, Ryan TP.
    Drug Metab Dispos; 2013 Jun 16; 41(6):1174-8. PubMed ID: 23569176
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Modulation of P-glycoprotein expression in hyperthyroid rat tissues.
    Nishio N, Katsura T, Ashida K, Okuda M, Inui K.
    Drug Metab Dispos; 2005 Nov 16; 33(11):1584-7. PubMed ID: 16079271
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Induction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 activation.
    Yousif S, Chaves C, Potin S, Margaill I, Scherrmann JM, Declèves X.
    J Neurochem; 2012 Nov 16; 123(4):491-503. PubMed ID: 22845665
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice.
    Uchida Y, Ohtsuki S, Kamiie J, Terasaki T.
    J Pharmacol Exp Ther; 2011 Nov 16; 339(2):579-88. PubMed ID: 21828264
    [Abstract] [Full Text] [Related]

  • 19. Brain penetration of WEB 2086 (Apafant) and dantrolene in Mdr1a (P-glycoprotein) and Bcrp knockout rats.
    Fuchs H, Kishimoto W, Gansser D, Tanswell P, Ishiguro N.
    Drug Metab Dispos; 2014 Oct 16; 42(10):1761-5. PubMed ID: 25053619
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.